Artesunate

Chemical NameArtesunate
Dosage FormInjection (intravenous; 110 mg in a single-dose via)
Drug ClassAntimalarials
SystemBlood
CompanyAmivas
Approval Year2020

Indication

  • Indicated for the initial treatment of severe malaria in adult and pediatric patients.
Last updated on 12/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Artesunate (artesunate) Prescribing Information.2020Amivas LLC, Wilmington DE
Document TitleYearSource
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.2019International Journal of Infectious Diseases
Document TitleYearSource
Review of UK malaria treatment guidelines 2016 (Public Health England Advisory Committee on Malaria Prevention).2018Archives of Disease in Childhood: Education & Practice